Cognition Therapeutics, Inc. (CGTX) Financials
CGTX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 38.9 million | 5.9 million |
| March 31, 2026 | 36.1 million | 6.2 million |
| Dec. 31, 2025 | 48.4 million | 14.1 million |
| Sept. 30, 2025 | 43.4 million | 6.9 million |
CGTX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -3.1 million | 319000 |
| March 31, 2026 | -5.5 million | 330000 |
| Dec. 31, 2025 | -3.4 million | 358000 |
| Sept. 30, 2025 | -5.7 million | 522000 |
CGTX Net Income
No data available :(
CGTX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 34.0 million | - | 511000 |
| March 31, 2026 | 31.1 million | - | 271000 |
| Dec. 31, 2025 | 37.0 million | - | 195000 |
| Sept. 30, 2025 | 39.8 million | - | 212000 |
CGTX Shares Outstanding
CGTX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 20000 | 5.1 million | 2.6 million | - |
| March 31, 2026 | - | 6.1 million | 2.7 million | - |
| Dec. 31, 2025 | - | 11.1 million | 2.5 million | - |
| Sept. 30, 2025 | - | 3.8 million | 2.6 million | - |
CGTX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | 68000 |
| Dec. 31, 2025 | - | 61000 |
| Sept. 30, 2025 | - | 61000 |
CGTX
Price: $0.73
52 week price:
Earnings Per Share: -0.17 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 239600
Market Capitalization: 84.0 million